JDRF-Authored Paper Shows Pathway To Accelerate Disease-Modi

JDRF-Authored Paper Shows Pathway To Accelerate Disease-Modifying Therapies For People With Type 1 Diabetes

C-peptide, a biomarker that indicates insulin production, is a validated surrogate endpoint in type 1 diabetes clinical trials NEW YO

Related Keywords

United States , Sanjoy Dutta , Esther Latres , Facebook , Research Esther Latres , Instagram , Journal Diabetes ,